Costs per 1000 pregnant women
|
Health provider excluding consequencesb (US$ 2012)
|
1631.84 (1100.11–2316.97)
|
5778.77 (4701.65–7039.15)a
|
Health provider including consequencesb (US$ 2012)
|
9006.54 (5610.30–13,680.56)
|
13,972.79 (10,199.65–18,983.86)a
|
Measurable outcomes contributing to DALYs per 1000 women [20]
|
LBW
|
151 (137–167)
|
156 (141–172)
|
severe/moderate anaemia
|
17 (12–25)
|
23 (17–32)
|
clinical malaria (total episodes)c
|
74 (61–92)
|
115 (96–144)
|
Other measurable outcomes per 1000 women and side effects [20, 37]
|
Placental malaria: active infection (acute and chronic)
|
245 (224–265)
|
242 (222–262)
|
Dizziness
|
46 (38–54)
|
25 (19–31)
|
Sleeplessness
|
13 (9–17)
|
7 (4–10)
|
Weakness
|
30 (24–37)
|
18 (13–23)
|
Nausea
|
22 (16–28)
|
13 (9–17)
|
Vomiting
|
45 (37–53)
|
26 (20–32)
|
Non measurable outcomes
|
Intrinsic value of giving less drugs to pregnant women
|
Value to individual of knowing about positive test
|
Value of knowing about positive test for surveillance
|
Deprivation of treatment for false negatives
|